Analysts anticipate Exact Sciences to report an earnings per share (EPS) of $0.02. Anticipation surrounds Exact Sciences's ...

LaMontagne will lead the commercial rollout of the company’s groundbreaking early-stage cancer detection test, Certitude.

Handheld saliva test detects breast cancer and even identifies its type, University of Florida researchers say. The device ...

The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.

Turning 50 brings a time for reflection and proactive health measures. Experts recommend scheduling a colonoscopy for early cancer detection, getting the shingles vaccine to prevent painful outbreaks ...

Your annual physical is keeping you alive, but it's probably not helping you thrive in midlife or in your later years. Here's ...

Thursday, July 31, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Costco ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...

Van Der Beek offered a reminder that colorectal cancer is one of the most curable types of cancer when it’s caught early and ...

The good news is that the shingles vaccine is highly effective. The Centers for Disease Control and Prevention recommends that adults 50 and older get the two-shot regimen, two to six months apart, ...

University research in Wisconsin led to $500 million Third Wave business, screening tests for cancer, including Cologuard ...